The future for CAR T-cells in treating AML
Venetoclax and ibrutinib and drug combinations for CLL
Present issues in treating patients with relapsed/refractory CLL
Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
Lenalidomide and ibrutinib: do they have a future in treating CLL?